Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Moyle

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
Expert Opinion on Investigational Drugs|July 5, 2005
A re-evaluation of zalcitabineG Moyle
Clinical Therapeutics|September 6, 2000
Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicityG Moyle
International Journal of Clinical Practice. Supplement|January 6, 2000
Efavirenz: practicalities, considerations and new issuesG Moyle
Drug Safety|January 6, 2001
Toxicity of antiretroviral nucleoside and nucleotide analogues: is mitochondrial toxicity the only mechanism?G Moyle
AIDS (London, England)|March 29, 2001
Mitochondrial toxicity hypothesis for lipoatrophy: a refutationG Moyle
The AIDS Reader|March 31, 2001
Use of HIV protease inhibitors as pharmacoenhancersG Moyle
International Journal of STD & AIDS|May 1, 1995
Influence of emergence of viral resistance on HIV treatment choiceG Moyle
Intervirology|January 1, 1994
HIV treatment choice based on resistance patternsG Moyle
Molecular Phylogenetics and Evolution|March 17, 2004
Phylogenetics of barbets (Aves: Piciformes) based on nuclear and mitochondrial DNA sequence dataRobert G Moyle
Evolution; International Journal of Organic Evolution|September 28, 2004
Calibration of molecular clocks and the biogeographic history of CrypteroniaceaeRobert G Moyle
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
Expert Opinion on Investigational Drugs|July 5, 2005
A re-evaluation of zalcitabineG Moyle
Clinical Therapeutics|September 6, 2000
Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicityG Moyle
International Journal of Clinical Practice. Supplement|January 6, 2000
Efavirenz: practicalities, considerations and new issuesG Moyle
Drug Safety|January 6, 2001
Toxicity of antiretroviral nucleoside and nucleotide analogues: is mitochondrial toxicity the only mechanism?G Moyle
AIDS (London, England)|March 29, 2001
Mitochondrial toxicity hypothesis for lipoatrophy: a refutationG Moyle
The AIDS Reader|March 31, 2001
Use of HIV protease inhibitors as pharmacoenhancersG Moyle
International Journal of STD & AIDS|May 1, 1995
Influence of emergence of viral resistance on HIV treatment choiceG Moyle
Intervirology|January 1, 1994
HIV treatment choice based on resistance patternsG Moyle
Molecular Phylogenetics and Evolution|March 17, 2004
Phylogenetics of barbets (Aves: Piciformes) based on nuclear and mitochondrial DNA sequence dataRobert G Moyle
Evolution; International Journal of Organic Evolution|September 28, 2004
Calibration of molecular clocks and the biogeographic history of CrypteroniaceaeRobert G Moyle
Pageof 15